Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
ClinicalTrials.gov study NCT02739594. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
ClinicalTrials.gov study NCT05354557. IPD Sharing: YES. Countries: 1. Publications: 0.
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00450814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01632826. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib
ClinicalTrials.gov study NCT04243109. IPD Sharing: YES. Countries: 1. Publications: 0.
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received T
ClinicalTrials.gov study NCT05828511. IPD Sharing: YES. Countries: 3. Publications: 0.
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
ClinicalTrials.gov study NCT03941860. IPD Sharing: YES. Countries: 2. Publications: 0.
Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00719901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function
ClinicalTrials.gov study NCT00718640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma
ClinicalTrials.gov study NCT00843310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00932217. IPD Sharing: Not stated. Countries: 0. Publications: 18.
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT04843579. IPD Sharing: NO. Countries: 1. Publications: 0.
Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05170789. IPD Sharing: NO. Countries: 0. Publications: 3.
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
ClinicalTrials.gov study NCT02619812. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT03236428. IPD Sharing: NO. Countries: 1. Publications: 0.
Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
ClinicalTrials.gov study NCT00171925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02389517. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01842308. IPD Sharing: Not stated. Countries: 1. Publications: 0.
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06956170. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00872521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.